CalciTech Files Full Year Results.

HAMILTON, Bermuda -- CalciTech Ltd. (OTCBB: CLKTF; Freiverkehr: XCH) today filed the Company's Consolidated Report and Financial Statements for the year ended 28th February 2005. Amounts referred to below are in thousands of US dollars.

For the year, CalciTech revenues increased from $51 to $75. Revenues derived from successful sale of commercial test samples of the Company's high-end SCC based products.

As the Company is now in the commercialization process, CalciTech was able to reduce R&D costs to zero, while investing $414 in project and product development. SG&A costs were reduced by $803 to $920 due to continuing efforts to reduce the Company's burn rate.

During the period under review, the Company posted a net loss of $1,668, compared to $2,244 for the equivalent period a year earlier. Under IAS, the Company's shareholder deficiency was $1,141 compared to $2,571 at the end of the financial year 2004. Part of the increase in net worth was the balance sheet strengthening following CalciTech's successful private placement, announced on 26th January 2005.

In October of 2004, CalciTech announced the results of extensive commercial trials carried out by potential clients for its SCC based products. The tests showed clearly that CalciTech's products are superior to other calcium carbonate products on the market today.

Based on these successful tests, CalciTech launched its third product, CalciRG(TM), aimed at the rotogravure market. Further tests showed that CalciRG(TM) can significantly enhance the competitive offering of kaolin based coatings mixtures when as little as 10% of the kaolin is replaced by CalciTech's SCC. The launch of this product formed an important part of the Company's strategy going forward as it allows the Company to team up with a strategic industrial partner.

Final field trials, carried out by BASF, one of the world's largest chemical corporations, showed again beyond doubt that CalciTech's SCC based product portfolio constitutes the latest generation of coatings products. Furthermore, the tests showed that the use of SCC has the potential of significantly improving the economics of the coatings process itself, thereby providing yet another strong selling point to the industry.

In order to enable the Company to accelerate its commercialization process and to further develop its marketing strategy regarding CalciRG(TM), CalciTech announced and successfully closed a $1,500 private placement. The placement, closed on 26th January 2005, was oversubscribed and totaled $2,250. The uptake of the placement was predominantly by existing shareholders, showing the strong support the Company enjoys from its shareholder base.

Also during the period under review it was announced that CalciTech had received Letters of Intent (LoI) accounting, when converted into contracts, cover the projected revenue for its first planned merchant facility in Germany. The LoIs have been coming in on the back of highly successful trial runs conducted by commercial, high-end paper producers.

The Company also came to an agreement with the MDSE in Germany for the exclusive access to a further 2.5 million tonnes of carbide lime waste at Schkopau, near Leuna. Carbide lime is a raw material for CalciTech's SCC manufacturing process. Securing rights over these ponds builds inventory for the lifetime of a project, at negligible cost.

During this period CalciTech announced that it successfully renegotiated 94% of the outstanding 5% debentures. Under the new terms, the debenture holders may convert into a future application for listing to a senior European or North American Stock Exchange or by 31st December, 2007, whichever maybe the earlier. The conversion price into the Company's Common Stock shall be US $1.75 per share. All other terms and conditions of the 5% convertible debenture remain unchanged.

This press release contains "forward looking statements" including forward looking statements as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Statements in this press release which are not purely historical are forward looking statements and include any statements regarding beliefs, expectation or intentions concerning the future. Forward looking statements in this press release include, but are not limited to statements which are subject to a number of contingencies and uncertainties, including, but not limited to, market acceptance for CalciTech products, manufacturing of CalciTech products in a commercial setting, obtaining adequate financing and construction management for products and obtaining appropriate permits.

It is important to note that the Corporation's actual outcomes may differ materially from those in forward looking statements contained in this press release. Although the Company believes that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations and intentions will prove to be accurate. Readers should refer to the risks disclosures in the Company's public filings with the Securities and Exchange Commission.